Nasdaq Vs. Aligos Therapeutics Industry Stock Comparison

Sell

46

NDAQ
Nasdaq

Last Price:

$78.42

Seasonality Move:

0.39%

Buy

62

ALGS
Aligos Therapeutics

Last Price:

$41.28

Seasonality Move:

-16.03%

Sell

46

Nasdaq (NDAQ) is a Sell

Is Nasdaq a Buy, Sell or Hold?

The current Nasdaq [NDAQ] share price is $78.42. The Score for NDAQ is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
NDAQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

62

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NDAQ Stock Price Chart

What is Nasdaq's stock price today?

The Nasdaq share price today is $78.42

The current trend is moderately bearish and NDAQ is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

The Aligos Therapeutics share price today is $41.15

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

NDAQ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.21	Sell
Relative Strength Index (14 RSI):	45.44	Sell
Chaikin Money Flow:	-471167	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(78.69 - 81.91)	Sell
Bollinger Bands (100):	(70.99 - 79.17)	Buy

ALGS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.69	Buy
Relative Strength Index (14 RSI):	73.75	Buy
Chaikin Money Flow:	-154898	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(23.72 - 37.64)	Buy
Bollinger Bands (100):	(6.81 - 25.85)	Buy

NDAQ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	78.32	Buy
20-day SMA:	79.92	Sell
50-day SMA:	78.5	Sell
200-day SMA:	68.27	Buy
8-day EMA:	78.74	Sell
20-day EMA:	79.26	Sell
50-day EMA:	78.1	Buy
200-day EMA:	69.92	Buy

ALGS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	38.54	Buy
20-day SMA:	33.12	Buy
50-day SMA:	21.28	Buy
200-day SMA:	16.61	Buy
8-day EMA:	38.79	Buy
20-day EMA:	33.47	Buy
50-day EMA:	25.09	Buy
200-day EMA:	18.34	Buy

Nasdaq Earnings Growth & NDAQ Earnings Dates

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $0.35 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Nasdaq Technical Analysis

	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27
	Dec
	13	16	17	18	19	20	23	24	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27
	Dec
	13	16	17	18	19	20	23	24	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):